Ottawa COPD Risk Scale
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low risk0–0
- Medium risk1–2
- High risk3–4
- Very high risk5–8
The Ottawa COPD Risk Scale calculates predicting 30-day mortality or serious adverse events (MI, intubation, etc) in emergency department COPD patients. Key inputs include coronary bypass graft. Scores guide determining acute hospital admission, emergency department discharge safety, or intensive care transfer. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Predicts 30-day mortality or serious adverse events (MI, intubation, etc) in emergency department COPD patients. Uses 10 clinical variables to stratify risk from low (2.2%) to very high (75.6%).
Clinical Indication
The Ottawa COPD Risk Scale is indicated for bedside clinical practice to support Predicts 30-day mortality or serious adverse events (MI, intubation, etc) in emergency department COPD patients. Uses 10 clinical variables to stratify risk from low (2.2%) to very high (75.6%).. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult and pediatric patients presenting with acute undifferentiated clinical complaints, trauma, or unstable vital signs. Clinical application is indicated across Emergency triage, acute resuscitation bays, observation units, and emergency trauma centers.
Limitations & Contraindications
Score calculations must never delay immediate life-saving airway stabilization, vascular access, or emergent surgical consult.
Clinical Pearls & Action Plan
Adherence to core ABCDE resuscitation principles and bedside clinical gestalt must take absolute precedence over numerical decision tools.
OCRS = (CABG × 1) + (PVD intervention × 1) + (Intubation history × 2) + (HR ≥110 × 2) + (Too ill for walk test × 2) + (Acute ischemic ECG × 2) + (Pulmonary congestion × 1) + (Hgb <10 × 3) + (Urea ≥12 × 1) + (CO2 ≥35 × 1)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| coronary_bypass_graft | string | Yes | History of coronary bypass graft (CABG) |
| peripheral_vascular_intervention | string | Yes | History of intervention for peripheral vascular disease |
| intubation_respiratory_distress | string | Yes | History of intubation for respiratory distress |
| heart_rate_110_or_higher | string | Yes | Heart rate ≥110 beats per minute on ED arrival |
| too_ill_for_walk_test | string | Yes | Too ill to do walk test after ED treatment |
| acute_ischemic_changes_ecg | string | Yes | Acute ischemic changes on ECG (clinician interpretation) |
| pulmonary_congestion_xray | string | Yes | Pulmonary congestion on chest x-ray (clinician interpretation) |
| hemoglobin_less_than_10 | string | Yes | Hemoglobin <10 g/dL |
| urea_12_or_higher | string | Yes | Urea ≥12 mmol/L (≥33.6 mg/dL) |
| serum_co2_35_or_higher | string | Yes | Serum CO2 ≥35 mEq/L |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Low risk | 2.2% risk of serious adverse events |
| 1–2 | Medium risk | 4.0-7.2% risk of serious adverse events |
| 3–4 | High risk | 12.5-20.9% risk of serious adverse events |
| 5–8 | Very high risk | 32.9-75.6% risk of serious adverse events |
| 9–10 | Extremely high risk | Risk >75% (not well studied) |
Evidence-Based References (EBM)
- Stiell IG, Clement CM, Aaron SD, Rowe BH, Perry JJ, Brison RJ, et al. Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study. CMAJ. 2014 Oct 7;186(15):E563-73. doi: 10.1503/cmaj.140677.DOI: 10.1503/cmaj.140677
- Stiell IG, Perry JJ, Clement CM, Brison RJ, Rowe BH, Aaron SD, et al. Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department. CMAJ. 2018 Oct 15;190(41):E1202-E1211. doi: 10.1503/cmaj.180232.DOI: 10.1503/cmaj.180232